Tuesday, June 30, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

ADCT — ADC Therapeutics SA SEC Filings | FilingIndex

ADCTNYSE

ADC Therapeutics SA

Pharmaceutical Preparations · V8 · CIK 1771910

Develops and commercializes antibody-drug conjugates for cancer treatment

+ Watch View on EDGAR ↗

$134M

Market cap

$1.03

Last close

+1.0%

1D

-5.5%

5D

1.0M

Volume

Price · last 39 sessions-72.0%

May 4L $0.98 · H $3.86Jun 29

190

Total filings

Jun 24, 2026

Last filing

12/31

Fiscal year end

All 6-K · 126 8-K · 33 10-Q · 7 DEF 14A · 4 SC 13G · 4 DEFA14A · 4 10-K · 3 20-F · 3

8-KReg FD Disclosure · Company UpdateJun 24, 2026 8-KReg FD Disclosure · Company UpdateJun 3, 2026 8-KShareholder VoteJun 2, 2026 8-KResults of OperationsMay 4, 2026 8-KResults of OperationsMar 10, 2026 8-K

Similar companies

Comparable business profile · signals at a glance

TBPHTheravance Biopharma, Inc.$857.8M-3.2%APGEApogee Therapeutics, Inc.🔥$6.7B+0.1%NKTRNEKTAR THERAPEUTICS$2.0B+2.7%LBRXLB PHARMACEUTICALS INC$815.0M+2.3%VKTX

Material Agreement · Equity Issuance

Feb 23, 2026

8-KReg FD DisclosureJan 12, 2026

8-KResults of Operations · Reg FD DisclosureJan 8, 2026

8-KCompany UpdateDec 5, 2025

8-KResults of OperationsNov 10, 2025

8-KMaterial Agreement · Results of OperationsOct 14, 2025

8-KReg FD DisclosureSep 30, 2025

8-KResults of OperationsAug 12, 2025

8-KMaterial Agreement · Exit / Disposal CostsJun 12, 2025

8-KShareholder VoteJun 5, 2025

8-KResults of OperationsMay 14, 2025

8-KResults of OperationsMar 27, 2025

8-KResults of Operations · Reg FD DisclosureJan 13, 2025

8-KShareholder VoteNov 13, 2024

8-KResults of OperationsNov 7, 2024

8-KResults of OperationsAug 6, 2024

8-KShareholder VoteJun 14, 2024

8-KReg FD DisclosureMay 14, 2024

8-KCompany UpdateMay 8, 2024

8-KResults of Operations · Reg FD DisclosureMay 6, 2024

8-KReg FD DisclosureApr 9, 2024

8-KResults of OperationsMar 13, 2024

8-KReg FD DisclosureMar 5, 2024

8-KExecutive ChangeFeb 29, 2024

8-KMaterial AgreementJan 24, 2024

8-KMaterial AgreementJan 19, 2024

8-KCompany UpdateJan 4, 2024

8-KResults of Operations · Reg FD DisclosureJan 4, 2024

Viking Therapeutics, Inc.

$3.3B

+3.9%

SPRBSPRUCE BIOSCIENCES, INC.$142.8M+1.4%